Latest News

Mutant-Allele Tumor Heterogeneity (MATH) in head, neck squamous cell carcinoma patients is effective marker, along with HPV status, of improved patient outcome

Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient?s HPV status provides an effective indicator of improved patient outcome, according to research.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • 'Off switch' for pain discovered: Activating the adenosine A3 receptor subtype is key to powerful pain relief

  • Full-day preschool linked with increased school readiness compared with part-day

  • Diagnosing deafness early will help teenagers' reading development

  • Why do people with autism see faces differently?

  • Sportswomen still second best to sportsmen, in the press

  • Inpatient psychotherapy is effective in Germany

  • How various brain areas interact in decisions

  • Pleasure at another's misfortune is evident in children as young as two

  • Isolation of important centres in brain results in age-related memory deficits

  • Prehistoric conflict hastened human brain's capacity for collaboration

  •